Atlas Trials

Phase 2 Study of Telintra® in Deletion 5q Myelodysplastic Syndrome

Clinical trial NCT01422486 · TERMINATED

Trial details

NCT number
NCT01422486
Sponsor
Telik
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Myelodysplastic Syndrome (MDS)
Start date
2011-10-01
Primary completion
2013-02-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.